Hormone Insight Editorial Team
Clinical archiveCan Diet and Metformin Improve Prediabetes?
A crossover trial finds a moderate-FODMAP diet plus metformin lowers postprandial glucose and raises GLP-1 in prediabetes, with microbiota shifts. PICO summary and commentary.
Is Dapagliflozin Safe in Hospitalised COVID-19 Patients With and Without Type 2 Diabetes?
A prespecified DARE-19 analysis found dapagliflozin was safe and well tolerated in hospitalised COVID-19 patients regardless of type 2 diabetes status, with no demonstrated efficacy benefit. PICO summary and expert commentary.
Which Add-On Works Better: Empagliflozin or Sitagliptin?
A double-blind RCT finds empagliflozin gives broader cardiometabolic benefit than sitagliptin or metformin as add-on therapy in type 2 diabetes. PICO summary and commentary.
